Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Immunotherapy in Sepsis: a Multicentre and Multinational, Double-blind, Double-dummy Randomized Clinical Trial

NCT04990232 is registered in ClinicalTrials.gov with Hellenic Institute for the Study of Sepsis as lead sponsor.

NCT NCT04990232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04990232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Immunotherapy in Sepsis: a Multicentre and Multinational, Double-blind, Double-dummy Randomized Clinical Trial
Lead sponsor
Hellenic Institute for the Study of Sepsis
Phase
Phase 2
Overall status
Completed
Start date
July 29, 2021
Completion date
April 27, 2024
Enrollment
280 (actual)
Sites
35

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis